We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$712M
AUM Growth
-$13.7M
Cap. Flow
+$11.2M
Cap. Flow %
1.57%
Top 10 Hldgs %
60.79%
Holding
765
New
119
Increased
141
Reduced
110
Closed
49

Sector Composition

Rank Sector Weight
1 Financials 8.55%
2 Technology 4.36%
3 Healthcare 2.88%
4 Consumer Discretionary 2.35%
5 Energy 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
401
Qorvo
QRVO
$8.39B
$12.7K ﹤0.01%
175
NUSC icon
402
Nuveen ESG Small-Cap ETF
NUSC
$1.32B
$12.6K ﹤0.01%
329
TFC icon
403
Truist Financial
TFC
$61.9B
$12.6K ﹤0.01%
306
GERN icon
404
Geron
GERN
$983M
$12.6K ﹤0.01%
7,900
PGR icon
405
Progressive
PGR
$129B
$12.5K ﹤0.01%
44
MAIN icon
406
Main Street Capital
MAIN
$5.46B
$12.4K ﹤0.01%
220
+1
+0.5% +$59
W icon
407
Wayfair
W
$14.2B
$12.3K ﹤0.01%
385
PTY icon
408
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$12.3K ﹤0.01%
850
KNSL icon
409
Kinsale Capital Group
KNSL
$8.82B
$12.2K ﹤0.01%
+25
New +$11.2K
XBI icon
410
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$12.2K ﹤0.01%
150
NLY icon
411
Annaly Capital Management
NLY
$17.2B
$12.1K ﹤0.01%
595
SPYM
412
State Street SPDR Portfolio S&P 500 ETF
SPYM
$170B
$12K ﹤0.01%
+183
New +$12.7K
KHC icon
413
Kraft Heinz
KHC
$29.4B
$11.8K ﹤0.01%
388
+57
+17% +$1.71K
DFTX
414
Definium Therapeutics
DFTX
$5.88B
$11.7K ﹤0.01%
1,999
ACWV icon
415
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.4B
$11.6K ﹤0.01%
100
PEO
416
Adams Natural Resources Fund
PEO
$795M
$11.4K ﹤0.01%
500
GRID
417
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$11.8B
$11.3K ﹤0.01%
100
SPLV icon
418
Invesco S&P 500 Low Volatility ETF
SPLV
$7.1B
$11.1K ﹤0.01%
149
MCHP icon
419
Microchip Technology
MCHP
$40.2B
$11K ﹤0.01%
228
-1,642
-88% -$91.5K
VYMI icon
420
Vanguard International High Dividend Yield ETF
VYMI
$21.5B
$10.9K ﹤0.01%
+148
New +$10.6K
ELV icon
421
Elevance Health
ELV
$87.3B
$10.9K ﹤0.01%
25
+3
+14% +$1.2K
SCM icon
422
Stellus Capital Investment Corp
SCM
$246M
$10.5K ﹤0.01%
750
IBB icon
423
iShares Biotechnology ETF
IBB
$10.8B
$10.5K ﹤0.01%
82
-150
-65% -$20.3K
GSK icon
424
GSK
GSK
$103B
$10.2K ﹤0.01%
264
EWW icon
425
iShares MSCI Mexico ETF
EWW
$1.8B
$10.2K ﹤0.01%
200

Similar funds

Crewe Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Crewe Advisors held 765 positions worth $712M, down 1.9% from $725M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Crewe Advisors's Q1 2025 filing shows 119 new, 141 increased, 110 reduced and 49 closed positions. Its largest new stake was Aspire Biopharma: 261 shares worth $183K. The largest sale was Berkshire Hathaway Class B, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.

  • Crewe Advisors's largest Q1 2025 buy was Aspire Biopharma: 261 shares worth $183K.
  • Crewe Advisors added most to iShares National Muni Bond ETF in Q1 2025, an estimated $9.71M increase.
  • Crewe Advisors's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $6.93M.
  • Crewe Advisors fully exited iShares 3-7 Year Treasury Bond ETF in Q1 2025, selling an estimated $754K.
  • Crewe Advisors's ten largest holdings make up 61% of its $712M portfolio in Q1 2025.
  • Crewe Advisors opened 119 new positions and closed 49 in Q1 2025.
  • Crewe Advisors's portfolio value fell 1.9% quarter-over-quarter to $712M.

Based on Crewe Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.